Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (5) , 736-742
- https://doi.org/10.1016/s0168-8278(98)80254-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis: A prospective, controlled pilot studyJournal of Hepatology, 1997
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis?Journal of Hepatology, 1995
- The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis: A 12-month double-blind, placebo-controlled trialJournal of Hepatology, 1994
- Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of diseaseDigestive Diseases and Sciences, 1994
- Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid aloneJournal of Hepatology, 1993
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992
- Immunosupressive therapy for primary biliary cirrhosisJournal of Hepatology, 1992
- Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?Journal of Hepatology, 1989
- The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosisJournal of Hepatology, 1986